Cargando…

Rare Skin Reactions after mRNA Vaccination, Similar to Jones–Mote Basophil Responses

Detalles Bibliográficos
Autor principal:	Askenase, Philip W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609603/ https://www.ncbi.nlm.nih.gov/pubmed/34706177 http://dx.doi.org/10.1056/NEJMc2111452

Ejemplares similares

CUTANEOUS BASOPHIL HYPERSENSITIVITY : I. A NEW LOOK AT THE JONES-MOTE REACTION, GENERAL CHARACTERISTICS
por: Richerson, Hal B., et al.
Publicado: (1970)

CUTANEOUS BASOPHIL (JONES-MOTE) HYPERSENSITIVITY AFTER "TOLEROGENIC" DOSES OF INTRAVENOUS OVALBUMIN IN THE GUINEA PIG
por: Richerson, Hal B.
Publicado: (1971)

Severe bullous drug reaction after COVID‐19 mRNA vaccination
por: Irmer, Marie Luise, et al.
Publicado: (2022)

Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
por: Alcaraz-Serna, Ana, et al.
Publicado: (2023)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

Letter from Samuel J. Jones, M.D.
por: Jones, Samuel J.
Publicado: (1868)

Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color
por: Samarakoon, Upeka, et al.
Publicado: (2021)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Bacillus Calmette-Guerin (BCG) Site Reaction after Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
por: Günaydın, Sibel Doğan, et al.
Publicado: (2023)

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Henry Bence Jones and Sir Benjamin Brodie
por: Moreton, A. L.
Publicado: (1921)

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
por: Zauche, Lauren H., et al.
Publicado: (2021)

Reply: Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Heo, Sang Taek
Publicado: (2022)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

mRNA vaccines and clinical research in Africa - From hope to reality
por: Saied, AbdulRahman A.
Publicado: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
por: Mungunpuntipantip, Rujittika, et al.
Publicado: (2023)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Central retinal artery occlusion after Moderna mRNA-1273 vaccination
por: Chow, Sin Yu, et al.
Publicado: (2022)

The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID‐19 vaccine
por: Labella, Marina, et al.
Publicado: (2021)

CUTANEOUS BASOPHIL HYPERSENSITIVITY IN CONTACT-SENSITIZED GUINEA PIGS : I. TRANSFER WITH IMMUNE SERUM
por: Askenase, P. W.
Publicado: (1973)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Exacerbation of Lupus Erythematosus Panniculitis After Administration of COVID-19 mRNA Vaccine
por: Avcı, Ceylan, et al.
Publicado: (2022)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction
por: Hoff, Norman-Philipp, et al.
Publicado: (2021)

Recurrent Paecilomyces Keratitis in a Patient with Jones Tube after Conjunctivodacryocystorhinostomy
por: Kim, Jong Ha, et al.
Publicado: (2016)

COVID‐19 mRNA‐1273 vaccine induces production of vaccine‐induced immune thrombotic thrombocytopenia antibodies
por: Padmanabhan, Anand, et al.
Publicado: (2022)

Correspondence on Body Weight, Anti-SARS-CoV-2 Antibody and mRNA Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine
por: Girolami, Ilaria, et al.
Publicado: (2022)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Bradley, Todd, et al.
Publicado: (2021)

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
por: Frey, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b2n8ubhqvk5i997pgg76rof9fl